Jiangsu Lanfeng Bio-Chemical announced that the company's controlling subsidiary Xuhe Technology intends to introduce investor Chang'an Trust for capital increase, with an amount of 98.01 million yuan, of which 17.82 million yuan is credited to registered capital and 80.19 million yuan is credited to capital reserves. The company and other existing shareholders of Xuhe Technology have waived their preferential subscription rights for the above capital increase. After this capital increase is completed, the company's shareholding ratio in Xuhe Technology will change from 51% to 49.2449%, and Xuhe Technology will still be the company's controlling subsidiary.
蓝丰生化：控股子公司旭合科技增资扩股引入投资者
Jiangsu Lanfeng Bio-Chemical: The controlling subsidiary Xuhe Technology is raising funds by introducing investors.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha